tiprankstipranks
Trending News
More News >
OncoTherapy Science, Inc. (JP:4564)
:4564

OncoTherapy Science (4564) Revenue

Compare
2 Followers

OncoTherapy Science Revenue

OncoTherapy Science had a revenue of 186.75M in the quarter ending Mar 31, 2025, with -44.75%. This bring the company's revenue in the last twelve months to 749.75M, Decreased 6.03%. In the fiscal year ending Mar 31, 2025, OncoTherapy Science had annual revenue of 750.05M with 22.93% growth.
Revenue (ttm)
749.75M
Revenue Growth
99.87%
P/S Ratio
11.76
Revenue/Employee
¥13,889,778
Employees
54
Market Cap
¥8.82B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2025
750.05M139.93M+22.93%
Mar 31, 2024
610.12M-524.78M-46.24%
Mar 31, 2022
1.13B802.43M+241.35%
Mar 31, 2021
332.48M-821.19M-71.18%
Mar 31, 2021
1.15B837.45M+264.84%
Mar 31, 2020
316.21M35.63M+12.70%
Mar 31, 2019
280.59M69.33M+32.82%
Mar 31, 2018
211.25M